{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T14:26:31Z","timestamp":1794839191895,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Center for Advancing Translational Sciences of the National Institutes of Health","award":["UL1TR002378\/TL1TR002382"],"award-info":[{"award-number":["UL1TR002378\/TL1TR002382"]}],"id":[{"id":"https:\/\/ror.org\/04pw6fb54","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32 CA275777Project-01A1"],"award-info":[{"award-number":["T32 CA275777Project-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1245\/s10434-026-20255-6","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T17:19:47Z","timestamp":1785777587000},"page":"11221-11231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Secondary Cytoreductive Surgery \u00b1 Hyperthermic Intraperitoneal Chemotherapy for Recurrent Colorectal Cancer Peritoneal Metastases"],"prefix":"10.1245","volume":"33","author":[{"given":"Kailey M.","family":"Oppat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances J.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Raoof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel M.","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harveshp D.","family":"Mogal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan B.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis E.","family":"Grotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith F.","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean P.","family":"Dineen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Powers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Y.","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua H.","family":"Winer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Staley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan M.","family":"Cloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shishir K.","family":"Maithel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3918-3954","authenticated-orcid":false,"given":"Seth J.","family":"Concors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"20255_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/bjs.8679","volume":"99","author":"J Segelman","year":"2012","unstructured":"Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A. Incidence, prevalence, and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2012;99:699\u2013705. https:\/\/doi.org\/10.1002\/bjs.8679.","journal-title":"Br J Surg."},{"key":"20255_CR2","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/s1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17:1709\u201319. https:\/\/doi.org\/10.1016\/s1470-2045(16)30500-9.","journal-title":"Lancet Oncol."},{"key":"20255_CR3","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1200\/jco.2004.10.012","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284\u201392. https:\/\/doi.org\/10.1200\/jco.2004.10.012.","journal-title":"J Clin Oncol."},{"key":"20255_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1200\/jco.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63\u20138. https:\/\/doi.org\/10.1200\/jco.2009.23.9285.","journal-title":"J Clin Oncol."},{"key":"20255_CR5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1245\/aso.2004.05.009","volume":"11","author":"P Shen","year":"2004","unstructured":"Shen P, Hawksworth J, Lovato J, et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol. 2004;11:178\u201386. https:\/\/doi.org\/10.1245\/aso.2004.05.009.","journal-title":"Ann Surg Oncol."},{"issue":"20","key":"20255_CR6","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/jco.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737\u201343. https:\/\/doi.org\/10.1200\/jco.2003.04.187.","journal-title":"J Clin Oncol."},{"key":"20255_CR7","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:2426\u201332. https:\/\/doi.org\/10.1245\/s10434-008-9966-2.","journal-title":"Ann Surg Oncol."},{"key":"20255_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/s1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:256\u201366. https:\/\/doi.org\/10.1016\/s1470-2045(20)30599-4.","journal-title":"Lancet Oncol."},{"key":"20255_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1245\/aso.2004.08.014","volume":"11","author":"VJ Verwaal","year":"2004","unstructured":"Verwaal VJ, Boot H, Aleman BM, van Tinteren H, Zoetmulder FA. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome. Ann Surg Oncol. 2004;11:375\u20139. https:\/\/doi.org\/10.1245\/aso.2004.08.014.","journal-title":"Ann Surg Oncol."},{"key":"20255_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ejso.2012.03.001","volume":"38","author":"PH Cashin","year":"2012","unstructured":"Cashin PH, Graf W, Nygren P, Mahteme H. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study. Eur J Surg Oncol. 2012;38:509\u201315. https:\/\/doi.org\/10.1016\/j.ejso.2012.03.001.","journal-title":"Eur J Surg Oncol."},{"key":"20255_CR11","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/jnci\/djab001v","volume":"113","author":"E Breuer","year":"2021","unstructured":"Breuer E, Hebeisen M, Schneider MA, et al. Site of recurrence and survival after surgery for colorectal peritoneal metastasis. J Natl Cancer Inst. 2021;113:1027\u201335. https:\/\/doi.org\/10.1093\/jnci\/djab001v.","journal-title":"J Natl Cancer Inst."},{"key":"20255_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030631","author":"MF Nielsen","year":"2024","unstructured":"Nielsen MF, Ravn S, S\u00f8rensen MM, Funder JA, Iversen LH. Recurrence and survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for synchronous and metachronous peritoneal metastases of colorectal origin. Cancers Basel. 2024. https:\/\/doi.org\/10.3390\/cancers16030631.","journal-title":"Cancers Basel"},{"key":"20255_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12957-024-03386-6","volume":"22","author":"M Sarofim","year":"2024","unstructured":"Sarofim M, Wijayawardana R, Ahmadi N, Morris DL. Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review. World J Surg Oncol. 2024;22:99. https:\/\/doi.org\/10.1186\/s12957-024-03386-6.","journal-title":"World J Surg Oncol."},{"key":"20255_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3978\/j.issn.2078-6891.2015.131","volume":"7","author":"H Mogal","year":"2016","unstructured":"Mogal H, Chouliaras K, Levine EA, Shen P, Votanopoulos KI. Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes. J Gastrointest Oncol. 2016;7:129\u201342. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2015.131.","journal-title":"J Gastrointest Oncol."},{"key":"20255_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.amjsurg.2019.09.017","volume":"219","author":"EW Beal","year":"2020","unstructured":"Beal EW, Ahmed A, Grotz T, et al. Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg. 2020;219:478\u201383. https:\/\/doi.org\/10.1016\/j.amjsurg.2019.09.017.","journal-title":"Am J Surg."},{"key":"20255_CR16","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). Updated 2 Feburary 2025. Retrieved 15 May 2025 at https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_50."},{"key":"20255_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b5087","volume":"340","author":"LE L\u00e9vesque","year":"2010","unstructured":"L\u00e9vesque LE, Hanley JA, Kezouh A, Suissa S. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ. 2010;340:b5087. https:\/\/doi.org\/10.1136\/bmj.b5087.","journal-title":"BMJ."},{"key":"20255_CR18","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1245\/s10434-020-08482-x","volume":"27","author":"BD Powers","year":"2020","unstructured":"Powers BD, Felder S, Veerapong J, et al. Repeat cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is not associated with prohibitive complications: results of a multiinstitutional retrospective study. Ann Surg Oncol. 2020;27:4883\u201391. https:\/\/doi.org\/10.1245\/s10434-020-08482-x.","journal-title":"Ann Surg Oncol."},{"key":"20255_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/tri.13081","volume":"31","author":"A Gleiss","year":"2018","unstructured":"Gleiss A, Oberbauer R, Heinze G. An unjustified benefit: immortal time bias in the analysis of time-dependent events. Transpl Int. 2018;31:125\u201330. https:\/\/doi.org\/10.1111\/tri.13081.","journal-title":"Transpl Int."},{"key":"20255_CR20","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1245\/s10434-021-09684-7","volume":"28","author":"S Laks","year":"2021","unstructured":"Laks S, Schtrechman G, Adileh M, et al. Repeat cytoreductive surgery and intraperitoneal chemotherapy for colorectal cancer peritoneal recurrences is safe and efficacious. Ann Surg Oncol. 2021;28:5330\u20138. https:\/\/doi.org\/10.1245\/s10434-021-09684-7.","journal-title":"Ann Surg Oncol."},{"key":"20255_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030607","author":"EM Pasqual","year":"2023","unstructured":"Pasqual EM, Londero AP, Robella M, et al. Repeated cytoreduction combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in selected patients affected by peritoneal metastases: Italian PSM Oncoteam evidence. Cancers Basel. 2023. https:\/\/doi.org\/10.3390\/cancers15030607.","journal-title":"Cancers Basel."},{"key":"20255_CR22","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1245\/s10434-019-07218-w","volume":"26","author":"HA Choudry","year":"2019","unstructured":"Choudry HA, Bednar F, Shuai Y, et al. Repeat cytoreductive surgery-hyperthermic intraperitoneal chemoperfusion is feasible and offers survival benefit in select patients with peritoneal metastases. Ann Surg Oncol. 2019;26:1445\u201353. https:\/\/doi.org\/10.1245\/s10434-019-07218-w.","journal-title":"Ann Surg Oncol."},{"key":"20255_CR23","doi-asserted-by":"publisher","first-page":"E71","DOI":"10.1503\/cjs.002519","volume":"63","author":"E Jost","year":"2020","unstructured":"Jost E, Mack LA, Sideris L, Dube P, Temple W, Bouchard-Fortier A. Evaluation of repeat cytoreductive surgery and heated intraperitoneal chemotherapy for patients with recurrent peritoneal carcinomatosis from appendiceal and colorectal cancers: a multicentre Canadian study. Can J Surg. 2020;63:E71\u20139. https:\/\/doi.org\/10.1503\/cjs.002519.","journal-title":"Can J Surg."},{"key":"20255_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/jso.23356","volume":"108","author":"TC Chua","year":"2013","unstructured":"Chua TC, Quinn LE, Zhao J, Morris DL. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases. J Surg Oncol. 2013;108:81\u20138. https:\/\/doi.org\/10.1002\/jso.23356.","journal-title":"J Surg Oncol."},{"key":"20255_CR25","doi-asserted-by":"publisher","unstructured":"The Chicago Consensus on peritoneal surface malignancies: management of colorectal metastases. Cancer. 2020;126:2534\u201340. https:\/\/doi.org\/10.1002\/cncr.32874.","DOI":"10.1002\/cncr.32874"},{"key":"20255_CR26","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/jso.23597","volume":"109","author":"HJ Braam","year":"2014","unstructured":"Braam HJ, van Oudheusden TR, de Hingh IH, et al. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. J Surg Oncol. 2014;109:841\u20137. https:\/\/doi.org\/10.1002\/jso.23597.","journal-title":"J Surg Oncol."},{"key":"20255_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1245\/s10434-024-16407-1","volume":"32","author":"F Tidadini","year":"2025","unstructured":"Tidadini F, Arvieux C, Glehen O, et al. Repeat cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using open and closed abdomen techniques for colorectal peritoneal metastases and peritoneal pseudomyxoma recurrences: results from six French expert centers. Ann Surg Oncol. 2025;32:209\u201320. https:\/\/doi.org\/10.1245\/s10434-024-16407-1.","journal-title":"Ann Surg Oncol."},{"key":"20255_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.sopen.2024.05.018","volume":"20","author":"PH Cashin","year":"2024","unstructured":"Cashin PH, Asplund D, Bexe Lindskog E, et al. Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal peritoneal metastases. Surg Open Sci. 2024;20:45\u201350. https:\/\/doi.org\/10.1016\/j.sopen.2024.05.018.","journal-title":"Surg Open Sci."},{"key":"20255_CR29","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1001\/jamasurg.2021.1642","volume":"156","author":"KP Rovers","year":"2021","unstructured":"Rovers KP, Bakkers C, Nienhuijs SW, et al. Perioperative systemic therapy vs cytoreductive surgery and hyperthermic intraperitoneal chemotherapy alone for resectable colorectal peritoneal metastases: a phase 2 randomized clinical trial. JAMA Surg. 2021;156:710\u201320. https:\/\/doi.org\/10.1001\/jamasurg.2021.1642.","journal-title":"JAMA Surg."},{"key":"20255_CR30","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ejso.2018.10.542","volume":"45","author":"W Ceelen","year":"2019","unstructured":"Ceelen W. HIPEC with oxaliplatin for colorectal peritoneal metastasis: the end of the road? Eur J Surg Oncol. 2019;45:400\u20132. https:\/\/doi.org\/10.1016\/j.ejso.2018.10.542.","journal-title":"Eur J Surg Oncol."},{"key":"20255_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/00015458.2019.1610260","volume":"119","author":"G Liberale","year":"2019","unstructured":"Liberale G, Ameye L, Hendlisz A. PRODIGE 7 should be interpreted with caution. Acta Chir Belg. 2019;119:263\u20136. https:\/\/doi.org\/10.1080\/00015458.2019.1610260.","journal-title":"Acta Chir Belg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20255-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20255-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20255-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T12:34:52Z","timestamp":1794832492000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20255-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":31,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["20255"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20255-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Seth J. Concors has received honoraria from Curio Lifesciences. The remaining authors have no conflicts of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}